NCT06181422View on ClinicalTrials.gov

Metformin and Lactoferrin in Sepsis in Icu

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

June 9, 2024

Study Completion Date

June 9, 2024

Conditions
Sepsis
Interventions
DRUG

Metformin

metformin 500 mg

DRUG

Lactoferrin

lactoferrin 100 mg

Trial Locations (1)

Unknown

RECRUITING

Tanta, Tanta

All Listed Sponsors
lead

Tanta University

OTHER